“The formation of Gain’s new Clinical Advisory Board marks a significant strategic step forward for Gain, as GT-02287 advances into Parkinson’s disease patients,” stated Gene ...

Gain Therapeutics (GANX) announced the formation of its Clinical Advisory Board, CAB, to support the continued development of the Company’s lead drug candidate, GT-02287, in Parkinson’s disease.

Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardiometabolic diseases, ...

Medcura, a hemostatic devicemaker, formed a Spinal Surgery Advisory Board, according to a Jan. 16 news release.

Gain Therapeutics (GANX) announced the formation of its Clinical Advisory Board, CAB, to support the continued development of the Company’s ...